Elisa M. Miguélez
University of Oviedo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Elisa M. Miguélez.
BioMed Research International | 2015
Laura Marín; Elisa M. Miguélez; Claudio J. Villar; Felipe Lombó
Polyphenolic compounds are plant nutraceuticals showing a huge structural diversity, including chlorogenic acids, hydrolyzable tannins, and flavonoids (flavonols, flavanones, flavan-3-ols, anthocyanidins, isoflavones, and flavones). Most of them occur as glycosylated derivatives in plants and foods. In order to become bioactive at human body, these polyphenols must undergo diverse intestinal transformations, due to the action of digestive enzymes, but also by the action of microbiota metabolism. After elimination of sugar tailoring (generating the corresponding aglycons) and diverse hydroxyl moieties, as well as further backbone reorganizations, the final absorbed compounds enter the portal vein circulation towards liver (where other enzymatic transformations take place) and from there to other organs, including behind the digestive tract or via blood towards urine excretion. During this transit along diverse tissues and organs, they are able to carry out strong antiviral, antibacterial, and antiparasitic activities. This paper revises and discusses these antimicrobial activities of dietary polyphenols and their relevance for human health, shedding light on the importance of polyphenols structure recognition by specific enzymes produced by intestinal microbial taxa.
Microbiology | 1993
Elisa M. Miguélez; Carlos Hardisson; Manuel B. Manzanal
SUMMARY: N-AcetyI-D-[1-14C]glucosamine ([14C]GlcNAc) was used to label specifically the cell wall in Streptomyces antibioticus. Lysozyme solubilized 86.5% of the radioactivity present in the trichloroacetic acid-precipitated and RNAase plus trypsin-digested fraction of hyphae pulse-labelled with [14C]GlcNAc for 3 min in a medium containing glucose, yeast extract and a mixture of nine amino acids. Experiments with [14C]GlcNAc-labelled hyphae revealed that growth of Streptomyces occurs without turnover of peptidoglycan. Autoradiographic analysis of S. antibioticus hyphae indicated that cell wall elongation occurs by intercalation of newly synthesized wall polymers at the tip, but also over a relatively broad zone that, depending on the hyphal length, extends up to 6-10 μm from the tip.
Frontiers in Microbiology | 2018
Serena Galié; Coral García-Gutiérrez; Elisa M. Miguélez; Claudio J. Villar; Felipe Lombó
Diverse microorganisms are able to grow on food matrixes and along food industry infrastructures. This growth may give rise to biofilms. This review summarizes, on the one hand, the current knowledge regarding the main bacterial species responsible for initial colonization, maturation and dispersal of food industry biofilms, as well as their associated health issues in dairy products, ready-to-eat foods and other food matrixes. These human pathogens include Bacillus cereus (which secretes toxins that can cause diarrhea and vomiting symptoms), Escherichia coli (which may include enterotoxigenic and even enterohemorrhagic strains), Listeria monocytogenes (a ubiquitous species in soil and water that can lead to abortion in pregnant women and other serious complications in children and the elderly), Salmonella enterica (which, when contaminating a food pipeline biofilm, may induce massive outbreaks and even death in children and elderly), and Staphylococcus aureus (known for its numerous enteric toxins). On the other hand, this review describes the currently available biofilm prevention and disruption methods in food factories, including steel surface modifications (such as nanoparticles with different metal oxides, nanocomposites, antimicrobial polymers, hydrogels or liposomes), cell-signaling inhibition strategies (such as lactic and citric acids), chemical treatments (such as ozone, quaternary ammonium compounds, NaOCl and other sanitizers), enzymatic disruption strategies (such as cellulases, proteases, glycosidases and DNAses), non-thermal plasma treatments, the use of bacteriophages (such as P100), bacteriocins (such us nisin), biosurfactants (such as lichenysin or surfactin) and plant essential oils (such as citral- or carvacrol-containing oils).
Journal of Cell Biology | 1999
Elisa M. Miguélez; Carlos Hardisson; Manuel B. Manzanal
Journal of Functional Foods | 2016
Javier Fernández; Saúl Redondo-Blanco; Ignacio Gutiérrez-del-Río; Elisa M. Miguélez; Claudio J. Villar; Felipe Lombó
International Microbiology | 2000
Elisa M. Miguélez; Carlos Hardisson; Manuel B. Manzanal
Fems Microbiology Letters | 2001
Begon¬a Rueda; Elisa M. Miguélez; Carlos Hardisson; Manuel B. Manzanal
Fems Microbiology Letters | 1992
Elisa M. Miguélez; Cruz Martín; Manuel B. Manzanal; Carlos Hardisson
Fems Microbiology Letters | 1993
Elisa M. Miguélez; Cruz Martín; Carlos Hardisson; Manuel B. Manzanal
Canadian Journal of Microbiology | 2001
Begoña Rueda; Elisa M. Miguélez; Carlos Hardisson; Manuel B. Manzanal